T1	Pharmacological_substance 55 67	methotrexate
N1000 	Reference T1 MeSH:D008727	methotrexate
T2	Disorder 76 87	anaphylaxis
N1 	Reference T2 UMLS:C0002792	anaphylaxis
T3	Pharmacological_substance 130 142	methotrexate
N1001 	Reference T3 MeSH:D008727	methotrexate
T4	Pharmacological_substance 170 182	methotrexate
N1002 	Reference T4 MeSH:D008727	methotrexate
T5	Disorder 191 202	anaphylaxis
N2 	Reference T5 UMLS:C0002792	anaphylaxis
T6	Disorder 258 263	death
N3 	Reference T6 UMLS:C1306577	death
T7	Pharmacological_substance 375 387	methotrexate
N1003 	Reference T7 MeSH:D008727	methotrexate
T8	Disorder 424 447	metastatic osteosarcoma
N4 	Reference T8 UMLS:C0278512	metastatic osteosarcoma
T9	Pharmacological_substance 507 519	methotrexate
N1004 	Reference T9 MeSH:D008727	methotrexate
T10	Pharmacological_substance 537 549	methotrexate
N1005 	Reference T10 MeSH:D008727	methotrexate
T11	Pharmacological_substance 639 651	methotrexate
N1006 	Reference T11 MeSH:D008727	methotrexate
T12	Disorder 821 827	cancer
N5 	Reference T12 UMLS:C0006826	cancer
N6 	Reference T12 UMLS:C1306459	cancer
T13	Pharmacological_substance 843 855	methotrexate
N1007 	Reference T13 MeSH:D008727	methotrexate
T14	Disorder 864 875	anaphylaxis
N7 	Reference T14 UMLS:C0002792	anaphylaxis
T17	Disorder 271 289	cancer progression
N8 	Reference T17 UMLS:C0178874	cancer progression
T18	Disorder 90 126	Anaphylactic/anaphylactoid reactions
N9 	Reference T18 UMLS:C0340865	Anaphylactic/anaphylactoid reactions
T20	Subject 411 418	a child
T21	Disorder 468 503	anaphylactic/anaphylactoid reaction
N10 	Reference T21 UMLS:C0340865	anaphylactic/anaphylactoid reaction
T24	Subject 807 815	patients
T26	Manner_cue 147 151	rare
